Carbon monoxide mediated inhibition of intimal hyperplasia

一氧化碳介导的内膜增生抑制

• 批准号: 7916718
• 负责人: Edith Tzeng
• 金额: --
• 依托单位: VETERANS HEALTH ADMINISTRATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-10-01 至 2014-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7916718
• 关键词: Acute; Adverse effects; Amputation; Angioplasty; Animal Model; Animals; Anti-Inflammatory Agents; Anti-inflammatory; Antioxidants; Apoptotic; Arterial Occlusive Diseases; Asphyxia; Atherosclerosis; Balloon Angioplasty; Binding; Biological Preservation; Blood Vessels; Breathing; Bypass; Carbon Monoxide; Cardiac; Cardiovascular system; Caring; Carrying Capacities; Cell Culture Techniques; Cell Proliferation; Cells; Cessation of life; Characteristics; Chronic; Clinical; Clinical Treatment; Congestive Heart Failure; Coronary; Coronary Arteriosclerosis; Coronary heart disease; Data; Development; Diabetes Mellitus; Diet Modification; Disease model; Dose; Endothelial Cells; Environment; Etiology; Event; Exposure to; Failure; Family suidae; Functional disorder; General Population; Goals; Grant; Healed; Healthcare; Healthcare Systems; Heart Diseases; Hemoglobin; Human; Hyperplasia; In Vitro; Incidence; Inflammatory; Inflammatory Response; Injury; Intervention; Ischemia; Kidney Failure; Knowledge; Lesion; Limb structure; Link; Lipids; Mediating; Medical; Metabolic syndrome; Modality; Modeling; Morbidity - disease rate; Myocardial Infarction; Myocardial Ischemia; Myocardial dysfunction; Nature; Non-Insulin-Dependent Diabetes Mellitus; Obesity; Operative Surgical Procedures; Oxygen; Pathology; Patient Care; Patients; Peripheral; Peripheral Vascular Diseases; Pharmaceutical Preparations; Physiological; Population; Prevention; Procedures; Property; Regimen; Rehabilitation therapy; Rodent; Role; Safety; Site; Smooth Muscle Myocytes; Stents; Stimulus; Stroke; Systemic disease; Therapeutic; Therapeutic Agents; Time; Tissues; Toxic Environmental Substances; Toxic effect; Translations; Treatment Efficacy; Treatment Failure; United States; Vascular Diseases; Vascular Patency; Veno-Occlusive Disease; Veterans; Work; base; cell type; clinically relevant; conventional therapy; defined contribution; functional status; healing; hemodynamics; improved; in vivo; mortality; neointima formation; operation; patient population; preclinical study; public health relevance; research study; response; response to injury; restenosis; stem; tobacco abuse; treatment duration